JY
Insider
James Emmett Young
Chief Financial OfficerJames Emmett Young (Chief Financial Officer) filed 1 Form 4 report in the past 24 months (1 purchase, 0 sales), most often in TriSalus Life Sciences, Inc. (TLSI). Across 1 priced purchase filing, the average 21-session return was +10.6% from execution and +11.6% from disclosure (delay-adjusted; derived). The largest single filing was $130K of TLSI (24,000 sh × $5.40, as filed), executed Jan 27 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
+10.6%
avg across 1 priced filings
Delay-adjustediThe same average, entered at disclosure dates
+11.6%
same 1 filings, from disclosure
Filings, ttm
1
1 buys · 0 sells
Median delay
2d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$130K
shares × price, as filed
Last traded
Jan 27 2025
Filed Jan 29 2025
Volume by month
Buys $130K
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 24 months
Most traded names
TLSIRecent filings
TLSIPURCHASE
TriSalus Life Sciences, Inc.
View filing →
$130K24,000 sh × $5.40
Exec Jan 27 2025
Filed Jan 29 2025 · 5:30 PM ET